Dr. Waseem Lone
About Candidate
As a Senior Scientist , I lead and contribute to cutting-edge research projects in the fields of molecular biology, cancer genomics, and translational medicine. My role involves designing and executing experiments, analyzing complex datasets, and interpreting findings to advance scientific knowledge and therapeutic development.
I collaborate with cross-functional teams, including clinicians, bioinformaticians, and junior researchers, to drive hypothesis-driven investigations and develop innovative strategies for disease modeling, biomarker discovery, and therapeutic targeting. I am responsible for writing and reviewing scientific manuscripts, grants, and protocols, as well as mentoring junior staff and overseeing lab operations to ensure scientific rigor and compliance with regulatory standards.
My work directly contributes to the development of novel diagnostics, targeted therapies, and personalized medicine approaches, aligning with institutional goals and broader scientific advancements.
Location
Education
During my doctoral research, I focused on the cytogenetic characterization and genetic counseling of hereditary disorders, with an emphasis on understanding chromosomal abnormalities and their clinical implications. My work involved karyotyping, FISH (fluorescence in situ hybridization), and pedigree analysis to identify patterns of inheritance and to support accurate diagnosis and counseling strategies for families affected by genetic conditions. I collaborated closely with clinicians and diagnostic labs to integrate cytogenetic findings into patient care, contributing to the development of region-specific counseling protocols. My research laid the foundation for my long-term interest in genetic and genomic alterations in human disease and established my expertise in the clinical application of genetics in both inherited disorders and malignancies.
Work & Experience
1. Post-Doctoral Research Associate (April 13, 2015 – March 20, 2020) During this period, Dr. Lone: o Investigated molecular mechanisms driving T-cell and B-cell lymphomagenesis using murine models and CRISPR-edited human T cells. o Conducted functional studies on epigenetic regulators and oncogenic mutations implicated in lymphoma progression. o Applied multi-omics approaches to identify potential therapeutic targets. o Published his findings in peer-reviewed journals and presented at international scientific conferences. 2. Senior Scientist (March 20, 2020 – December 31, 2024) In this role, Dr. Lone: o Led research on the molecular mechanisms underlying aggressive B- and T-cell non-Hodgkin lymphomas arising from the germinal center reaction. o Developed and characterized murine models to investigate lymphoma pathogenesis. o Explored the role of genetic and epigenetic alterations, including mutations in TET2, IDH2R172, and DNMT3A, in lymphomagenesis. o Studied B-cell receptor (BCR) signaling dynamics and their contribution to lymphoma development. o Supervised and mentored graduate students and junior researchers, promoting collaborative research and scientific innovation. o Published extensively in peer-reviewed journals and represented the institution at global scientific forums.
